SHOULD ANTIBODIES TO DOMAIN I B2-GLYCOPROTEIN 1 BE INVESTIGATED IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME (APS) AND SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)?

被引：1
|
作者：
Cheldieva, F. [1 ,2 ]
Reshetnyak, T. [1 ,2 ]
Cherkasova, M. [1 ]
Glukhova, S. [3 ]
Lila, A. [2 ]
Nasonov, E. [3 ]
机构：
[1] VA Nasonova Res Inst Rheumatol, Lab Thromboinflammat, Moscow, Russia
[2] Minist Hlth Russia, Russian Med Acad Continuing Profess Educ, Dept Rheumatol, Moscow, Russia
[3] VA Nasonova Res Inst Rheumatol, Dept Rheumatol, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.2329
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0496
引用
收藏
页码：1374 / 1375
页数：2
相关论文
共 50 条
  • [21] Antiphospholipid syndrome nephropathy in systemic lupus erythematosus patients with antiphospholipid antibodies
    Tektonidou, MG
    Sotsiou, F
    Nakopoulou, L
    Vtachoyiannopoulos, PG
    Moutsopoulos, HM
    THROMBOSIS RESEARCH, 2004, 114 (5-6) : 609 - 610
  • [22] ANTIPHOSPHOLIPID ANTIBODIES, ANTIPHOSPHOLIPID SYNDROME AND THROMBOSES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Seredavkina, N.
    Reshetnyak, T.
    Satybaldyeva, M.
    Aleksandrova, E.
    Novikov, A.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1100 - 1100
  • [23] Anti-prothrombin immunoassays as predictors of antiphospholipid syndrome (APS) in systemic lupus erythematosus (SLE).
    Petri, MA
    Cakir, B
    Roubey, RAS
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S369 - S369
  • [24] DIFFERENT MANIFESTATIONS OF THE ANTIPHOSPHOLIPID ANTIBODY SYNDROME (APS) IN A FAMILY WITH SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    MAY, KP
    WEST, SG
    KOTZIN, BL
    ARTHRITIS AND RHEUMATISM, 1993, 36 (05): : R10 - R10
  • [25] Antibodies to β2-glycoprotein I:: A potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus
    Sanfilippo, SS
    Khamashta, MA
    Atsumi, T
    Amengual, O
    Bertolaccini, ML
    D'Cruz, D
    Amft, N
    Swana, GT
    Hughes, GRV
    JOURNAL OF RHEUMATOLOGY, 1998, 25 (11) : 2131 - 2134
  • [26] Immune responses to native β2-glycoprotein I in patients with systemic lupus erythematosus and the antiphospholipid syndrome
    Davies, ML
    Young, SP
    Welsh, K
    Bunce, M
    Wordsworth, BP
    Davies, KA
    Wagenknecht, DR
    Taylor, E
    Gordon, C
    Jobson, S
    Briggs, D
    Bowman, SJ
    RHEUMATOLOGY, 2002, 41 (04) : 395 - 400
  • [27] Thromboembolism in pediatric systemic lupus erythematosus (SLE) patients with antiphospholipid antibodies.
    Miller, DL
    Massicotte, MP
    Harvey, E
    Hebert, D
    Silverman, ED
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S384 - S384
  • [28] Thromboembolism in pediatric systemic lupus erythematosus (SLE) patients with antiphospholipid antibodies.
    Levy, D
    Massicotte, P
    Harvey, E
    Hebert, D
    Silverman, E
    JOURNAL OF RHEUMATOLOGY, 2001, 28 (06) : 1419 - 1419
  • [29] Antibodies to Domain I of β2Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)
    Banzato, A.
    Pozzi, N.
    Frasson, R.
    De Filippis, V.
    Ruffatti, A.
    Bison, E.
    Padayattil, S. J.
    Denas, G.
    Pengo, V.
    THROMBOSIS RESEARCH, 2011, 128 (06) : 583 - 586
  • [30] Inadequate Screening for Antiphospholipid Syndrome with Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus
    Munawar, Tooba
    Sherazi, Mahnoor
    Perl, Andras
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1810 - 1811
12345